Literature DB >> 27078171

Innate immune cell response upon Candida albicans infection.

Yulin Qin1, Lulu Zhang1, Zheng Xu1, Jinyu Zhang1, Yuan-Ying Jiang1, Yongbing Cao1, Tianhua Yan2.   

Abstract

Candida albicans is a polymorphic fungus which is the predominant cause of superficial and deep tissue fungal infections. This microorganism has developed efficient strategies to invade the host and evade host defense systems. However, the host immune system will be prepared for defense against the microbe by recognition of receptors, activation of signal transduction pathways and cooperation of immune cells. As a consequence, C. albicans could either be eliminated by immune cells rapidly or disseminate hematogenously, leading to life-threatening systemic infections. The interplay between Candida albicans and the host is complex, requiring recognition of the invaded pathogens, activation of intricate pathways and collaboration of various immune cells. In this review, we will focus on the effects of innate immunity that emphasize the first line protection of host defense against invaded C. albicans including the basis of receptor-mediated recognition and the mechanisms of cell-mediated immunity.

Entities:  

Keywords:  Candida albicans; immune cells; innate immunity; receptor-mediated recognition; signal transduction

Mesh:

Substances:

Year:  2016        PMID: 27078171      PMCID: PMC5026795          DOI: 10.1080/21505594.2016.1138201

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  145 in total

Review 1.  Macrophage receptors implicated in the "adaptive" form of innate immunity.

Authors:  D M E Bowdish; M S Loffredo; S Mukhopadhyay; Alberto Mantovani; S Gordon
Journal:  Microbes Infect       Date:  2007-09-14       Impact factor: 2.700

2.  NKp30 enables NK cells to act naturally with fungi.

Authors:  Jessica Quintin; Stuart M Levitz
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

3.  Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.

Authors:  Brad J Spellberg; Ashraf S Ibrahim; Valentina Avanesian; Yue Fu; Carter Myers; Quynh T Phan; Scott G Filler; Michael R Yeaman; John E Edwards
Journal:  J Infect Dis       Date:  2006-06-06       Impact factor: 5.226

4.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1.

Authors:  J F Staab; S D Bradway; P L Fidel; P Sundstrom
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

5.  Host cell invasion and virulence mediated by Candida albicans Ssa1.

Authors:  Jianing N Sun; Norma V Solis; Quynh T Phan; Jashanjot S Bajwa; Helena Kashleva; Angela Thompson; Yaoping Liu; Anna Dongari-Bagtzoglou; Mira Edgerton; Scott G Filler
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

6.  Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.

Authors:  L Maródi; S Schreiber; D C Anderson; R P MacDermott; H M Korchak; R B Johnston
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans.

Authors:  Christine A Wells; Judith A Salvage-Jones; Xin Li; Kelly Hitchens; Suzanne Butcher; Rachael Z Murray; Anthony G Beckhouse; Yu-Lan-Sandra Lo; Silvia Manzanero; Christian Cobbold; Kate Schroder; Bo Ma; Sally Orr; Lauren Stewart; Daniel Lebus; Peter Sobieszczuk; David A Hume; Jennifer Stow; Helen Blanchard; Robert B Ashman
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 8.  Vaccines in the treatment of invasive candidiasis.

Authors:  Xiao-juan Wang; Xue Sui; Lan Yan; Yan Wang; Yong-bing Cao; Yuan-ying Jiang
Journal:  Virulence       Date:  2015-01-06       Impact factor: 5.882

Review 9.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

10.  The pathogen Candida albicans hijacks pyroptosis for escape from macrophages.

Authors:  Nathalie Uwamahoro; Jiyoti Verma-Gaur; Hsin-Hui Shen; Yue Qu; Rowena Lewis; Jingxiong Lu; Keith Bambery; Seth L Masters; James E Vince; Thomas Naderer; Ana Traven
Journal:  MBio       Date:  2014-03-25       Impact factor: 7.867

View more
  19 in total

1.  Candida albicans triggers a differential profile of microRNAs depending on its growing form.

Authors:  Carlos Del Fresno Sánchez
Journal:  Virulence       Date:  2016-07-21       Impact factor: 5.882

2.  Dectin-1 embraces Candida glabrata.

Authors:  Carlos Del Fresno Sánchez
Journal:  Virulence       Date:  2017-08-24       Impact factor: 5.882

3.  Genetic Screening of Candida albicans Inactivation Mutants Identifies New Genes Involved in Macrophage-Fungal Cell Interactions.

Authors:  Pablo Godoy; Peter John Darlington; Malcolm Whiteway
Journal:  Front Microbiol       Date:  2022-04-05       Impact factor: 6.064

Review 4.  Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion.

Authors:  Gaëlle Angrand; Alicia Quillévéré; Nadège Loaëc; Chrysoula Daskalogianni; Anton Granzhan; Marie-Paule Teulade-Fichou; Robin Fahraeus; Rodrigo Prado Martins; Marc Blondel
Journal:  Genes (Basel)       Date:  2019-08-31       Impact factor: 4.096

5.  Investigation of Antifungal Properties of Synthetic Dimethyl-4-Bromo-1-(Substituted Benzoyl) Pyrrolo[1,2-a] Quinoline-2,3-Dicarboxylates Analogues: Molecular Docking Studies and Conceptual DFT-Based Chemical Reactivity Descriptors and Pharmacokinetics Evaluation.

Authors:  Vijayakumar Uppar; Sandeep Chandrashekharappa; Chandan Shivamallu; Sushma P; Shiva Prasad Kollur; Joaquín Ortega-Castro; Juan Frau; Norma Flores-Holguín; Atiyaparveen I Basarikatti; Mallikarjun Chougala; Mrudula Mohan M; Govindappa Banuprakash; Katharigatta N Venugopala; Belakatte P Nandeshwarappa; Ravindra Veerapur; Abdulaziz A Al-Kheraif; Abdallah M Elgorban; Asad Syed; Kiran K Mudnakudu-Nagaraju; Basavaraj Padmashali; Daniel Glossman-Mitnik
Journal:  Molecules       Date:  2021-05-06       Impact factor: 4.411

6.  GLUT3 as an Intersection of Glycerophospholipid Metabolism and the Innate Immune Response to Candida albicans.

Authors:  Xian Wu; Ge Zhang; Wen-Hang Yang; Jing-Tao Cui; Li Zhang; Meng Xiao; Ying-Chun Xu
Journal:  Front Cell Infect Microbiol       Date:  2021-06-18       Impact factor: 5.293

Review 7.  Recurrent candidal intertrigo: challenges and solutions.

Authors:  Ahmet Metin; Nursel Dilek; Serap Gunes Bilgili
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-04-17

Review 8.  Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy.

Authors:  Linda Davidson; Mihai G Netea; Bart Jan Kullberg
Journal:  J Fungi (Basel)       Date:  2018-01-09

9.  Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular Stresses.

Authors:  Suraya Muzafar; Ravi Datta Sharma; Abdul Haseeb Shah; Naseem A Gaur; Ujjaini Dasgupta; Neeraj Chauhan; Rajendra Prasad
Journal:  mSphere       Date:  2020-08-12       Impact factor: 4.389

Review 10.  Platelets in Sepsis: An Update on Experimental Models and Clinical Data.

Authors:  Alice Assinger; Waltraud C Schrottmaier; Manuel Salzmann; Julie Rayes
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.